Dosage and administration
Advance formula, use a small amount only. Apply evenly over clean skin until fully absorbed. Apply as needed before sun exposure. Keep the sunscreen tube away from direct sunlight to preserve its efficiency.
Advance formula, use a small amount only. Apply evenly over clean skin until fully absorbed. Apply as needed before sun exposure. Keep the sunscreen tube away from direct sunlight to preserve its efficiency.
IQQU
Advance Sunscreen
SPF 35 UVA/UVB
Dimethicone, Butyl Methoxydibenzoylmethane, Titanium Dioxide, Octyl Methoxycinnamate.
Advance formula, use a small amount only. Apply evenly over clean skin until fully absorbed. Apply as needed before sun exposure.
Keep the sunscreen tube away from direct sunlight to preserve its efficiency.
For external use only. Avoid contact with the eyes. Discontinue use if signs of irritation occurs. Keep out of children’s reach.
Isononyl Isonanonate, Glyceryl Stearate, Cyclopentasiloxane (and) Dimethicone, Cyclopentasiloxane (and) C30-45 Alkyl Cetearyl Dimethicone Crosspolymer, Talcum
Manufactured by: June Laboratories Co., Ltd.
1014 Soi Wat Channai, Sathupradit Rd,
Bangkok 10120 Thailand.
Made in Thailand
Package Label – 30 mL
IQQU Advance Sunscreen
SPF 35 UVA/UVB
30 mL /1.01 oz
| Class | Version | Type | Effective |
|---|---|---|---|
| DIMETHICONE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50403-999-92 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-ccff-621f-e053-dbdaa90a74ad | Advance Sunscreen |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50403-999-92 | IQQU Advance Sunscreen | 30 mL in 1 TUBE | LOTION | 30 | 3 | |
| 50403-999-92 | IQQU Advance Sunscreen | 1 in 1 CARTON | LOTION | 1 | 3 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50403-999 | IQQU ADVANCE SUNSCREEN (DIMETHICONE AND BUTYL METHOXYDIBENZOYLMETHANE AND TITANIUM DIOXIDE AND OCTYL METHOXYCINNAMATE) LOTION [IQQU USA CO.] | 3 | Legacy NDC, 2 package rows | 20100205_e35234bf-ee75-4cb6-8984-e5ed4a293696.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 3 | |
| DIMETHICONE | ACTIVE INGREDIENT | 92RU3N3Y1O | 3 | |
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 3 | |
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 3 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 3 | |
| DIMETHICONE | ACTIVE MOIETY | 92RU3N3Y1O | 3 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 3 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 3 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 50403-999 | 50403-999-92 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DIMETHICONE | 92RU3N3Y1O | ACTIB |
| AVOBENZONE | G63QQF2NOX | ACTIB |
| TITANIUM DIOXIDE | 15FIX9V2JP | ACTIB |
| OCTINOXATE | 4Y5P7MUD51 | ACTIB |
| GLYCERYL MONOSTEARATE | 230OU9XXE4 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | EMULSION / ORAL | NA | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | SUSPENSION / OPHTHALMIC | 0.5 %w/v | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | GRANULE, FOR SUSPENSION / ORAL | 4 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET / ORAL | 33.34 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LIQUID / TOPICAL | 1 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CREAM / VAGINAL | 140 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | AEROSOL, FOAM / TOPICAL | 3.27 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | OINTMENT / TOPICAL | 5 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE, DELAYED RELEASE / ORAL | 15 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET / SUBLINGUAL | 1.23 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 23 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, EXTENDED RELEASE / ORAL | 529 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CREAM / TOPICAL | 836 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, DELAYED RELEASE / ORAL | 6 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, CHEWABLE / ORAL | 1 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | AEROSOL, FOAM / VAGINAL | 3 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | SUPPOSITORY / RECTAL | 35 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE / ORAL | 13.75 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE, EXTENDED RELEASE / ORAL | 32.4 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2083b860-64a8-4ea5-b56f-5af21f82bb2a | e35234bf-ee75-4cb6-8984-e5ed4a293696 | 2010-02-07 | Warnings | 2083b860-64a8-4ea5-b56f-5af21f82bb2a e35234bf-ee75-4cb6-8984-e5ed4a293696 |
Adverse event summaries are temporarily unavailable. Other product information remains available.